Trial intelligence / Profile preview

Prednisone for Cognition in Community-Acquired Pneumonia

NCT04652414Phase 2Withdrawn

Sponsor
Vanderbilt University Medical Center
Start
Dec 2020
Primary completion
Jul 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of prednisone in community acquired pneumonia (CAP), sponsored by Vanderbilt University Medical Center. Planned start Dec 2020; status: withdrawn.

02

Drugs

prednisone
03

Conditions

community acquired pneumonia (CAP)

Beyond the preview

Go deeper on NCT04652414.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04652414.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call